Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.
Thymalin at a glance
- What it is
- A polypeptide complex (multiple low-molecular-weight peptides, <10 kDa) extracted from calf thymus tissue, developed as a peptide bioregulator by the Khavinson research group.
- Researched for
- Immune modulation, T-cell function, and geroprotective (anti-aging) effects in Russian clinical and community research.
- Commonly reported range
- 5-10 mg per day (community and Russian clinical protocols); reconstitution here is concentration math only, not a personal dose.
- Route reported
- Intramuscular (IM) in original clinical work; subcutaneous (SubQ) widely reported in the community.
- Reported frequency
- Once daily during a short course.
- Reported cycle
- 5-10 consecutive days per course, courses repeated roughly every 3-6 months in reported protocols.
- Plasma half-life
- Not well characterized; individual peptide fractions are reported to clear rapidly (minutes to a few hours), while biological effects are reported to persist much longer.
- Regulatory status
- Registered as an immunomodulatory medicine in Russia; not FDA-approved and not EMA-approved; sold in the US and elsewhere as a research-use-only chemical.
Reported ranges from research/community — examples, not recommendations.
What it is / mechanism
Thymalin is not a single molecule but a standardized complex of low-molecular-weight peptides (reported below roughly 10 kDa) isolated from thymus tissue. In the peptide-bioregulator model advanced by the Khavinson group, these short peptides are proposed to act as signaling molecules that the aging thymus can no longer produce in sufficient quantity. At the molecular level, the peptide fractions are reported to interact with double-stranded DNA and histone proteins and to modulate the expression of genes involved in immune-cell differentiation. Reported downstream effects include supporting T-lymphocyte maturation, restoring interleukin-2 (IL-2) production, and influencing calcium-driven activation cascades in thymocytes and macrophages. Because Thymalin is a mixture rather than a defined single peptide, its pharmacology is less precisely characterized than that of synthetic single-sequence peptides such as thymosin alpha-1.
Researched effects
Reported effects in Russian clinical literature and community use include restoration of T-cell counts and CD4/CD8 balance in older or immunocompromised subjects, increased natural killer (NK) cell activity, normalization of cytokine signaling, and reduced frequency of respiratory infections. Longitudinal Khavinson research reported reduced all-cause mortality in elderly cohorts, with the largest reductions when Thymalin was combined with the pineal peptide Epitalon (Epithalamin). These are research findings and community reports, not guaranteed outcomes; much of the strongest data comes from older Russian studies that have not been widely replicated under modern Western trial standards.
Evidence & regulatory status
- Evidence: Reported in Russian clinical trials and decades of Khavinson-group longitudinal research as an immunomodulator, with reported reductions in respiratory infection rates and all-cause mortality in elderly cohorts; independent Western replication is limited.
- Regulatory: Registered as an immunomodulatory medicine in Russia (Ministry of Health registration); not approved by the FDA or EMA; not evaluated for safety or efficacy by US regulators.
- Research use: In the US and most Western markets Thymalin is sold strictly as a research-use-only chemical, not for human consumption or clinical use.
Dosage — reported ranges (overview)
The following are examples of what is reported in Russian protocols and community practice, not a recommendation. Reported courses commonly use 5-10 mg once daily for 5-10 consecutive days, with the 10 mg/day, 10-day course being the most-cited elderly-immune protocol and 5 mg/day used as a lighter maintenance course. Courses are typically reported as being repeated every 3-6 months rather than run continuously. Thymalin is dosed in milligrams (mg), so the calculations below give concentration in mg per milliliter and the corresponding volume on an insulin syringe, not a suggested amount to take.
A printable protocol sheet with a reconstitution reference and an injection log comes with All-Access Lifetime.
Reconstitution — bac-water math
Thymalin ships as a lyophilized (freeze-dried) powder and is reconstituted with bacteriostatic water before use. Because Thymalin is dosed in milligrams, the useful figure is concentration in mg/mL: divide the vial's total milligrams by the milliliters of water added. On a U-100 insulin syringe, 1 mL equals 100 units, so units drawn = (desired mg / mg-per-mL) x 100. Worked example for a representative 10 mg vial: adding 1 mL of bacteriostatic water gives 10 mg/mL, so a 5 mg amount is 0.5 mL (50 units) and the full 10 mg is 1.0 mL (100 units). Adding more water lowers the concentration and raises the volume for the same milligram figure.
| Bac water added | Concentration | 5 mg amount | 10 mg amount |
|---|
| 1 mL | 10 mg/mL | 0.5 mL (50 units) | 1.0 mL (100 units) |
| 2 mL | 5 mg/mL | 1.0 mL (100 units) | 2.0 mL (200 units, split into 2 injections) |
| 3 mL | 3.33 mg/mL | 1.5 mL (150 units) | 3.0 mL (300 units, split into injections) |
This is concentration math, not a dose recommendation.
Injection / administration basics
In the original clinical work Thymalin was given by intramuscular injection; subcutaneous injection at the same milligram amount is widely reported in the community with reportedly comparable results. Because a full 10 mg amount can exceed the 1 mL capacity of a standard insulin syringe at lower concentrations, using less water (higher concentration) keeps injection volumes small. Reconstituted powder is drawn with a U-100 insulin syringe. These are handling notes only, not medical advice or a suggestion to inject.
Half-life & frequency rationale
A precise plasma half-life for Thymalin is not well established because it is a mixture of peptides rather than one defined molecule. Individual short-peptide fractions are generally reported to clear the bloodstream rapidly (on the order of minutes to a few hours), while the reported biological effects on immune signaling are described as persisting far longer, which is part of the rationale for short intermittent courses rather than continuous dosing. For context, the related defined peptide thymosin alpha-1 has a reported half-life of roughly two hours.
Side effects, safety & contraindications
Reported tolerability in the Russian literature is generally described as good, with the most commonly noted effects being injection-site reactions (redness, soreness) and occasional allergic-type responses, consistent with an animal-tissue-derived product. Because Thymalin is an immunomodulator, theoretical concerns include unpredictable effects in people with autoimmune conditions or those on immunosuppressive therapy. Human safety data outside older Russian studies is limited, and long-term controlled safety data under modern Western standards is lacking. This is not a complete safety profile and not medical advice.
Stacking — overview
Thymalin is most classically paired with other Khavinson peptide bioregulators, and the reported combinations below are examples from the literature and community, not recommendations. The best-documented pairing is with Epitalon (the pineal bioregulator), the combination reported in Khavinson's longevity studies. It is also community-stacked with other immune and repair peptides. Anyone combining compounds should recognize that combination data is largely anecdotal outside the Thymalin-plus-Epitalon longitudinal work.
Khavinson bioregulator pairing
Thymalin + Epithalon (immune + pineal bioregulators)
Immune stack
Thymalin + Thymosin Alpha-1 (thymic immune-support pairing)
Stacking across compounds
The overview above covers Thymalin. The cross-compound material — which pairings are redundant rather than additive, where interaction risk is documented versus merely unstudied, and the blend arithmetic worked end to end — lives in the Peptide Stacking Guide, which is free to read in outline and $39 in full (included with All-Access Lifetime).
Included with this guide
The Thymalin Stacking Module
The overview above is the free summary. The Thymalin Stacking Module goes through each combination in depth — the mechanism-level reason it is proposed, what is actually reported in practice, and the cautions specific to that pairing — plus what to avoid and why. Included with Thymalin Standard Access.
- How to think about stacking Thymalin — 4 principles
- 3 combinations covered in detail
- What to avoid, and why — 3 items
- Combination-specific cautions
Combinations covered: Khavinson bioregulator pairing, Immune stack, Bioregulator trio.
For how combinations are grouped by research context, the named blends, and why a pre-mixed blend vial cannot be calculated from its total milligrams, see the peptide stacks guide.
Storage & handling
- Lyophilized (powder): store in a freezer or refrigerator, protected from light; the dry powder is reported to remain stable for extended periods when kept cold and sealed.
- Reconstituted (in bacteriostatic water): keep refrigerated (about 2-8 C) and use within roughly 2-4 weeks; do not freeze the reconstituted solution.
References
Compiled from Khavinson-group publications on peptide bioregulators, Russian clinical trial summaries, and peptide research references; all figures are reported examples for educational use only and not medical advice.
Related peptide guides
Continue exploring related educational guide topics in the Medibact library.
Guide FAQ
Quick answers about guide scope, access, and educational use context.
Is Thymalin the same as Thymosin Alpha-1 or Thymulin?
No. Thymalin is a complex mixture of several low-molecular-weight peptides extracted from thymus tissue. Thymosin alpha-1 is a single defined 28-amino-acid synthetic peptide, and Thymulin is a separate defined nonapeptide. They are related in origin and target but are distinct compounds with different characterization.
Is Thymalin approved by the FDA?
No. Thymalin is registered as an immunomodulatory medicine in Russia but is not approved by the FDA or EMA. In the US it is sold only as a research-use-only chemical, not for human use, and it has not been evaluated by US regulators for safety or efficacy.
Why are the reported doses given in milligrams rather than mcg?
Thymalin is dosed at the milligram scale in reported protocols (commonly 5-10 mg per course-day), unlike many peptides dosed in micrograms. Reconstitution therefore focuses on mg/mL concentration and the corresponding syringe volume.
How long is a typical reported course?
Reported protocols commonly describe 5-10 consecutive days of once-daily injection making up one course, with courses repeated roughly every 3-6 months rather than run continuously. This reflects the reported model of short intermittent bioregulator courses.
Is Thymalin banned in sport?
Thymalin is not named individually on the WADA Prohibited List, but as a non-approved substance it can fall under the catch-all S0 category (substances not approved for human use), which WADA treats as prohibited at all times. Athletes should not assume it is permitted.
Compliance and trust notes
- Educational content only; no personalized health or outcome claims.
- No personalized use recommendation outputs.
- Use this material for general learning and research-context literacy.
